Compare DAIO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAIO | MYO |
|---|---|---|
| Founded | 1969 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 44.8M |
| IPO Year | 1995 | 2017 |
| Metric | DAIO | MYO |
|---|---|---|
| Price | $3.12 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.22 | ★ $7.67 |
| AVG Volume (30 Days) | 39.5K | ★ 648.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,500,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | $4.51 | $9.10 |
| Revenue Next Year | $30.29 | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $2.16 | $0.61 |
| 52 Week High | $4.49 | $2.14 |
| Indicator | DAIO | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 34.34 | 45.95 |
| Support Level | $2.98 | $0.99 |
| Resistance Level | $3.26 | $1.13 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 2.82 | 40.28 |
Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.